Navigation Links
Dry Eye Survey: Ophthalmologists Cite Treatment Limitations/Gaps in Treatment of Moderate to Severe Dry Eye
Date:11/10/2008

LAWRENCEVILLE, N.J., Nov. 10 /PRNewswire/ -- Aton Pharma, Inc., a diversified specialty pharmaceutical company, announced results of a recent survey of ophthalmologists regarding issues in the treatment of moderate to severe cases of dry eye. Aton provides the dry eye medication Lacrisert(R) (hydroxypropyl cellulose ophthalmic insert), a preservative-free, once-daily*, sustained release prescription insert that helps to retain moisture, stabilize the tear film, and lubricate the eye.

Nearly all of the ophthalmologists surveyed (94%) believe more treatment options are needed for moderate to severe dry eye. While 80% feel current therapies are effective for mild dry eye, only 33% feel they are effective for moderate dry eye and 67% feel they are only somewhat effective or not very effective. Only 5% feel current therapies are effective for severe dry eye, while 56% feel they are somewhat effective and 38%, not very or not at all effective.

"Ophthalmologists are still looking for more effective therapies for treating moderate to severe dry eye," commented Dr. Penny Asbell, Professor, Department of Ophthalmology, Mount Sinai School of Medicine; Director, Cornea Services and Refractive Surgery Center, New York; and co-author of the pivotal textbook 'Dry Eye Disease, the Clinician's Guide to Diagnosis and Treatment.' "Nearly all ophthalmologists want more treatment options for these more serious cases." Dr. Asbell is a member of Aton Pharma's Scientific Advisory Board.

"We are proud to be working with Dr. Asbell to contribute to eye care professionals' insights about the state of the art of treatment of dry eye," stated Michael G. Wells, Chief Executive Officer of Aton Pharma. "Ophthalmology is one of the important markets Aton serves as a diversified specialty pharmaceutical company providing medically essential therapies to patients around the world."

Treatment Approaches and Options

The survey respondents reported that over the
'/>"/>

SOURCE Aton Pharma, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Survey: 90% of Participating Surgeons Report Syndicom SpineConnect Improves Practice of Spine Surgery
2. AstraZeneca Survey: Healthcare Professionals Leading Source of Information on Companys Prescription Savings Programs
3. Wedgewood Pharmacy Will Continue to Provide Avastin(R) to Ophthalmologists and Retinal Specialists
4. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
5. Johns Hopkins to add Elekta Synergy S(R) to Cancer Treatment Lineup
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
8. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
9. IDM Pharma Receives Not Approvable Letter for Mifamurtide (L-MTP-PE) for the Treatment of Osteosarcoma
10. FDA Grants Orphan Drug Designation to TREANDA, an Investigational Treatment for Chronic Lymphocytic Leukemia
11. Elekta To Showcase Innovations in Radiotherapy and Unveil New Product That Expands Cancer Treatment Availability
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , Dec. 24, 2014  United Therapeutics Corporation ... Medtronic, Inc. (NYSE: MDT ) has ... Food and Drug Administration (FDA) for the use ... infusion system (including a newly developed catheter) for ... Injection delivered intravenously to patients with pulmonary arterial ...
(Date:12/24/2014)... 23, 2014 “Preparative & Process ... Flash), Consumables (Columns, Solvents, Buffers, Valves, Guages, Seals), ... Agriculture) - Forecasts to 2019” provides a detailed ... current market trends, and strategies impacting the preparative ... and forecasts of the revenue and share analysis. ...
(Date:12/24/2014)... 2014 On Friday, December 19, ... the Omnibus and Continuing Resolution Appropriations Act of ... a condition eligible to receive funding through the ... the Department of Defense (DoD). The Hydrocephalus Association ... Capitol Hill, is celebrating this victory for the ...
(Date:12/24/2014)... report expects global cell isolation and expansion market to ... carefully analyzed data about the vital drivers, restraints, trends, ... Copy of Report @ http://bit.ly/1yUxy0T , According ... will keep witnessing growth at an impressive CAGR during ... by rapid technological advancements, government funding and investments, and ...
Breaking Biology Technology:United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 2Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 4Rare Brain Condition Now Eligible for Department of Defense Research Dollars 2The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 2The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 3
... 10, 2010 Marshall Edwards, Inc.(Nasdaq: MSHL ), ... anti-cancer therapeutics, announced today that Daniel P. Gold, Ph.D., President ... Edwards and its lead oncology programs at the Lazard Capital ... p.m. EST from the St. Regis New York. A live ...
... the Negev,s Prof. Ron Folman has been named as a recipient ... and Quantum Optics. The award is presented annually in ... of Willis E. Lamb Jr., who was the 1955 winner of ... a member of BGU,s Ilse Katz Institute for Nanoscale Science and ...
... 2010 Verenium Corporation (Nasdaq: VRNM ... industrial enzyme solutions, today reported a summary of recent Company ... "I am pleased with the significant progress made ... see solid progress growing and diversifying our product sales and ...
Cached Biology Technology:Verenium Reports Financial Results for the Third Quarter 2010 2Verenium Reports Financial Results for the Third Quarter 2010 3Verenium Reports Financial Results for the Third Quarter 2010 4Verenium Reports Financial Results for the Third Quarter 2010 5Verenium Reports Financial Results for the Third Quarter 2010 6Verenium Reports Financial Results for the Third Quarter 2010 7Verenium Reports Financial Results for the Third Quarter 2010 8Verenium Reports Financial Results for the Third Quarter 2010 9
(Date:12/19/2014)... Dec. 18, 2014  23andMe, Inc., the leading personal ... that pinpoints fine-scale differences in genetic ancestry of individuals ... Since immigrants first arrived more than four ... has served as a meeting place for peoples ... and the ongoing mixing of peoples with African, European, ...
(Date:12/17/2014)... Dec. 15, 2014  HITLAB SM announced ... (GCP) audit to confirm its adherence to current ... accomplishment enables HITLAB to conduct regulated smart device ... principles for patient safety and research quality. ... access, quality, and delivery with innovative technology," said ...
(Date:12/15/2014)... , Dec. 12, 2014 Research and ... the addition of the "Global Facial Recognition ... http://photos.prnewswire.com/prnh/20130307/600769 ... identification of individuals. Facial recognition system measures the ... nose, jaw edges, mouth, and the distance between ...
Breaking Biology News(10 mins):23andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3
... transplant patients reject their new organs requires a working ... each other. Xavier Fernndez-Busquets, an MBL researcher visiting from ... in this quest: the red beard sea sponge, an ... Cape Cod down to Florida. , , The ...
... of the snow-free season in Alaska's tundra, and a corresponding ... be creating a cycle of warmer and longer summers in ... published in the Sept. 22, 2005, issue of Science Express. ... Alaska is equivalent to what might be observed if there ...
... researchers and their colleagues have their way, cheetahs, lions, elephants, ... of North America. , "If we only have 10 ... Harry Greene, professor of ecology and evolutionary biology at Cornell. ... haven't thought about this as much as we have. Right ...
Cached Biology News:Simple sea sponge helps scientists understand tissue rejection 2Lands surface change on Alaska tundra creating longer, warmer summers in Arctic 2Proposal would allow wild animals to roam North America 2Proposal would allow wild animals to roam North America 3
... An entire pressurized perfusion system for ... physiology, biophysics, electrochemistry, or general liquid-handling ... little as 100 microliters of precious ... solutions in milliseconds from a single ...
Request Info...
Anti-Digoxigenin-AP, Fab fragments; from sheep...
384 Cluster Tube Racks...
Biology Products: